Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-21 Purchase |
2021-04-23 7:58 pm |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
2,352 | $17 | $39,984 | 2,352 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:44 pm |
NeuroPace Inc | NPCE | Accelmed Partners II L.P. 10% Owner |
588,235 | $17 | $9,999,995 | 588,235 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:43 pm |
NeuroPace Inc | NPCE | Fischer Frank M Director |
50,000 | $17 | $850,000 | 114,989 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:27 pm |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
13,235 | $17 | $224,995 | 60,551 (Direct) |
View |
| 2021-04-21 Purchase |
2021-04-23 7:26 pm |
NeuroPace Inc | NPCE | Norton Evan Director |
588,235 | $17 | $9,999,995 | 588,235 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-21 Option Award |
2021-04-23 7:43 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Fischer Frank M Director |
21,698 | $0 | 114,989 (Direct) |
View |
| 2021-04-21 Option Award |
2021-04-23 7:27 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
21,698 | $0 | 60,551 (Direct) |
View |
Ownership |
2021-04-20 5:34 pm |
N/A N/A |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical officer |
0 | $0 | 293,942 (Direct) |
View |
Ownership |
2021-04-20 5:34 pm |
N/A N/A |
NeuroPace Inc | NPCE | KCK LTD. 10% Owner |
0 | $0 | 5,621,111 (Direct) |
View |
Ownership |
2021-04-20 5:33 pm |
N/A N/A |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
0 | $0 | 352,112 (Direct) |
View |
Ownership |
2021-04-20 5:32 pm |
N/A N/A |
NeuroPace Inc | NPCE | Fischer Frank M Director |
0 | $0 | 515,657 (Direct) |
View |
Ownership |
2021-04-20 5:31 pm |
N/A 2031-01-20 |
NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary |
0 | $0 | 92,308 (Direct) |
View |
Ownership |
2021-04-20 5:31 pm |
N/A N/A |
NeuroPace Inc | NPCE | Accelmed Partners II L.P. 10% Owner |
0 | $0 | 3,454,422 (Direct) |
View |
Ownership |
2021-04-20 5:30 pm |
N/A N/A |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
0 | $0 | 3,777,281 (Indirect) |
View |
Ownership |
2021-04-20 5:29 pm |
N/A N/A |
NeuroPace Inc | NPCE | Ryan Renee Director |
0 | $0 | 41,170 (Direct) |
View |
Ownership |
2021-04-20 5:28 pm |
N/A N/A |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
0 | $0 | 211,441 (Direct) |
View |
Ownership |
2021-04-20 5:26 pm |
N/A N/A |
NeuroPace Inc | NPCE | Norton Evan Director |
0 | $0 | 3,454,422 (Indirect) |
View |
Ownership |
2021-04-20 5:25 pm |
N/A N/A |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
0 | $0 | 1,035,453 (Indirect) |
View |
Ownership |
2021-04-20 5:25 pm |
N/A N/A |
NeuroPace Inc | NPCE | Garfield Greg Shaw Director |
0 | $0 | 5,640,002 (Indirect) |
View |